Insights Series S2E2: Prof. Benza about why CS1 is such an exciting drug candidate in PAH

Raymond L. Benza, System Director of Pulmonary Hypertension at Mount Sinai Icahn School of Medicine, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board, speaks about why CS1 is such an exciting drug in PAH.

Watch here >

English subtitles are available.

This video is episode 2 in the Insights Series season 2 and was recorded at the ESC Congress in August 2023.